US pharma behemoth Pfizer Inc (NYSE:PFE) and German company BioNTech SE (Nasdaq: BNTX) have signed another deal with the US government to supply an additional COVID-19 vaccine dose. With the new agreement, the Companies will supply additional 100 million doses of BNT162b2 from its US based manufacturing facilities.
The two partners anticipate providing total 200 million vaccine doses to Operation Warp Speed (OWS) by the end of July 2021.
Moreover, in line with the previous agreement that was announced in July 2020, the government shall pay almost US$1.95 billion for the new deal of 100 million BNT162b2 doses.
This new purchase by the US government can offer Americans even more confidence that the nation will have enough COVID-19 vaccine supply to vaccinate every person in the US who wants the vaccine by June 2021.
Under the terms of this new agreement, the two vaccine developers will provide minimum 70 million of the additional doses by the end of June 2021 and the residual 30 million doses of the vaccine are targeted to be supplied by the end of July 2021.
Besides, the US government also has the option to acquire additional 400 million doses of the COVID-19 vaccine- BNT162b2.